CD4 and neoplasm: Some reports have associated the accumulation of CD4+FOXP3+CD25hi Tregs with poor prognosis owing to the suppression of anti-tumor immune response [49–56], and altered Treg number and function has been reported in patients receiving conventional or immune therapies [57–59].